Valuation: Divi's Laboratories Limited

Market Cap 2,640B 27.89B 24.9B 22.85B 20.78B 38.97B 39.74B 273B 110B 1,394B 105B 102B 4,402B P/E 2027 *
80.7x
P/E 2028 * 66.7x
Enterprise Value 2,605B 27.51B 24.56B 22.54B 20.5B 38.44B 39.21B 269B 109B 1,375B 103B 101B 4,342B EV / Sales 2027 *
20.6x
EV / Sales 2028 * 17.3x
Free-Float
48%
Yield 2027 *
0.35%
Yield 2028 * 0.39%
1 day+1.19%
1 week+5.88%
Current month+2.90%
1 month+9.44%
3 months+17.23%
6 months+52.04%
Current year+57.43%
1 week 9,370
Extreme 9370
10,064
1 month 8,797
Extreme 8797
10,064
Current year 5,647.5
Extreme 5647.5
10,064
1 year 5,647.5
Extreme 5647.5
10,064
3 years 3,295.3
Extreme 3295.3
10,064
5 years 2,730
Extreme 2730
10,064
10 years 532.65
Extreme 532.65
10,064
Manager TitleAgeSince
Chief Executive Officer 75 26/11/2009
Chief Executive Officer 49 04/01/2020
Director of Finance/CFO 65 01/08/2025
Director TitleAgeSince
Director/Board Member 49 26/11/2009
Chairman 75 26/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap. Importance
26/3/25 Sell

Executive/Senior Manager

25,000 0.0094%
15/3/25 Sell 300 0.0001%
17/2/25 Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+1.19%+5.88%+47.91%+200.36% 27.89B
-0.46%+10.31%+63.52%+143.15% 1,257B
-0.97%+1.60%+43.25%+80.09% 651B
-2.05%+0.73%+32.47%+101.62% 510B
+0.06%-0.35%+53.22%+67.59% 388B
-0.78%+5.51%+72.55%+44.25% 366B
+0.85%+3.11%+33.45%+59.32% 303B
+0.11%+8.30%+12.31%+35.21% 288B
-0.12%+4.68%+55.97%+74.59% 252B
-0.21%+7.34%+42.19%+109.69% 211B
Average -0.18%+5.12%+45.68%+91.59% 425.45B
Weighted average by Cap. -0.34%+5.33%+49.31%+94.49%

Financials

2027 *2028 *
Net sales 126B 1.33B 1.19B 1.09B 993M 1.86B 1.9B 13.04B 5.26B 66.6B 5B 4.9B 210B 150B 1.59B 1.42B 1.3B 1.18B 2.22B 2.26B 15.55B 6.27B 79.41B 5.96B 5.84B 251B
Net income 32.66B 345M 308M 283M 257M 482M 492M 3.38B 1.36B 17.24B 1.29B 1.27B 54.45B 39.6B 418M 373M 343M 312M 585M 596M 4.09B 1.65B 20.9B 1.57B 1.54B 66.02B
Net Debt -35.52B -375M -335M -307M -280M -524M -535M -3.67B -1.48B -18.75B -1.41B -1.38B -59.21B -45.03B -476M -425M -390M -354M -665M -678M -4.65B -1.88B -23.77B -1.79B -1.75B -75.07B
Projected Income Statement - Annual - Divi's Laboratories Limited
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
03/11/26 INR 10,064.00 +1.19% 611,334
02/11/26 INR 9,945.50 +1.69% 914,498
30/10/26 INR 9,780.00 +1.20% 1,027,380
29/10/26 INR 9,664.00 +1.10% 395,258
28/10/26 INR 9,558.50 +0.56% 745,043
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Divi's Laboratories Limited
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
29
Last Close Price
9,945.50INR
Average target price
8,612.17INR
Spread / Average Target
-13.41%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Divi's Laboratories Limited
  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock